EcoDrugPlus

Ensembl ID : ENSFHEG00000017629
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSFHEG00000002399
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSFHEG00000018933
Gene Symbol: -
Cross references: -
218 Possible Orthologues:

Ensembl ID : ENSFHEG00000020812
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSFHEG00000001570
Gene Symbol: -
Cross references: -
146 Possible Orthologues:

Ensembl ID : ENSFHEG00000021594
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSFHEG00000021616
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSFHEG00000021637
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSFHEG00000022197
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSFHEG00000000980
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSFHEG00000022641
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSFHEG00000022223
Gene Symbol: -
Cross references: -
232 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).